Please provide your email address to receive an email when new articles are posted on . Decreases in mental health scores after glaucoma diagnosis may be associated with fears of vision loss or ...
In a pivotal clinical trial, an excimer laser procedure reduced IOP in patients with glaucoma, according to a press release ...
Nucleoside and nucleotide reverse transcriptase inhibitors use remained significantly associated with an increased risk for developing primary open-angle glaucoma after adjustment for family history.
Elevated systolic blood pressure (BP) and pulse pressure were associated with an increased risk of incident primary open-angle glaucoma. There was no significant association between diastolic BP and ...
The daily use of eye drops containing 0.002% omidenepag isopropyl reduced intraocular pressure and was well‐tolerated in patients newly diagnosed with primary open‐angle glaucoma who had not ...
DEDHAM, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc., a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced positive topline results from two ...
15d
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma
Detailed price information for Bausch Lomb Corporation (BLCO-T) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results